Meta-analysis of gene expression for development and validation of a diagnostic biomarker panel for Oral Squamous Cell Carcinoma

We use a newly developed feature extraction and classification method to analyze previously published gene expression data sets in Oral Squamous Cell Carcinoma and in healthy oral mucosa in order to find a gene set sufficient for diagnoses. The feature selection technology is based on the relative dichotomy power concept published by us earlier. The resulting biomarker panel has 100% sensitivity and 95% specificity, is enriched in genes associated with oncogenesis and invasive tumor growth, and, unlike marker panels devised in earlier studies, shows concordance with previously published marker genes.

[1]  Keith L. Ligon,et al.  Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples , 2009, PloS one.

[2]  Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma , 2018, Journal of experimental & clinical cancer research : CR.

[3]  C. Sawyers.  The cancer biomarker problem , 2008, Nature.

[4]  Dong Eun Kim,et al.  Detection of MAGE and SSX Gene Expressions by RT-nested PCR Using Common Primers in Head and Neck Cancer , 2008, Clinical and experimental otorhinolaryngology.

[5]  Martin Dugas,et al.  Quantitative comparison of microarray experiments with published leukemia related gene expression signatures , 2009, BMC Bioinformatics.

[6]  Lue Ping Zhao,et al.  Can a Metastatic Gene Expression Profile Outperform Tumor Size as a Predictor of Occult Lymph Node Metastasis in Oral Cancer Patients? , 2011, Clinical Cancer Research.

[7]  A. Walch,et al.  A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy‐treated head and neck squamous cell carcinoma (HNSCC) , 2018, Molecular oncology.

[8]  Pedro Larrañaga,et al.  A review of feature selection techniques in bioinformatics , 2007, Bioinform..

[9]  Sabri Boughorbel,et al.  Optimal classifier for imbalanced data using Matthews Correlation Coefficient metric , 2017, PloS one.

[10]  Peter Bühlmann,et al.  Analyzing gene expression data in terms of gene sets: methodological issues , 2007, Bioinform..

[11]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[12]  Li Mao,et al.  Transcriptomic dissection of tongue squamous cell carcinoma , 2008, BMC Genomics.

[13]  Li Mao,et al.  Gene Expression Profiling Predicts the Development of Oral Cancer , 2011, Cancer Prevention Research.

[14]  Vladimir Makarov,et al.  Computational method for discovery of biomarker signatures from large, complex data sets , 2018, Comput. Biol. Chem..

[15]  Jin-Kao Hao,et al.  Advances in metaheuristics for gene selection and classification of microarray data , 2010, Briefings Bioinform..

[16]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[17]  Yang Zhao,et al.  Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma , 2017, Clinical Epigenetics.

[18]  B. Matthews.  Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.

[19]  Qiang Zhu,et al.  Twenty-four signature genes predict the prognosis of oral squamous cell carcinoma with high accuracy and repeatability , 2017, Molecular medicine reports.

[20]  Hsueh-Wei Chang,et al.  Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[21]  Hiroshi Tanaka,et al.  Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  K. Strimbu,et al.  What are biomarkers? , 2010, Current opinion in HIV and AIDS.

[23]  D. Brasnu,et al.  A Head and Neck Cancer Tumor Response-Specific Gene Signature for Cisplatin, 5-Fluorouracil Induction Chemotherapy Fails with Added Taxanes , 2012, PLoS ONE.

[24]  Yorgos Goletsis,et al.  A multiscale and multiparametric approach for modeling the progression of oral cancer , 2012, BMC Medical Informatics and Decision Making.

[25]  Ed Schuuring,et al.  Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  T. Day,et al.  Oral Cancer and Precancerous Lesions , 2002, CA: a cancer journal for clinicians.

[27]  N. Futran,et al.  Tumor and Salivary Matrix Metalloproteinase Levels Are Strong Diagnostic Markers of Oral Squamous Cell Carcinoma , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[28]  E. Prakash,et al.  CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. , 2008, Carcinogenesis.

[29]  E. Tajara,et al.  Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites , 2008, BMC Research Notes.

[30]  R. Ng,et al.  Genomic imbalances in precancerous tissues signal oral cancer risk , 2009, Molecular Cancer.

[31]  M. Nicolau,et al.  Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data , 2015, Oncotarget.

[32]  Ziding Feng,et al.  Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population , 2016, Clinical Cancer Research.

[33]  S. Nomura,et al.  Gene expression profiling to predict recurrence of advanced squamous cell carcinoma of the tongue: discovery and external validation , 2017, Oncotarget.

[34]  J. Werner,et al.  Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer. , 2002, Anticancer research.

[35]  J. M. Menke,et al.  More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers , 2017, Biomarkers in cancer.

[36]  Ju-Seog Lee,et al.  SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma , 2018, Scientific Reports.

[37]  I. Frazer,et al.  The overexpression of salivary cytokeratins as potential diagnostic biomarkers in head and neck squamous cell carcinomas , 2017, Oncotarget.

[38]  E. Mardis,et al.  A Surprising Cross-Species Conservation in the Genomic Landscape of Mouse and Human Oral Cancer Identifies a Transcriptional Signature Predicting Metastatic Disease , 2014, Clinical Cancer Research.

[39]  N. Futran,et al.  A 13-Gene Signature Prognostic of HPV-Negative OSCC: Discovery and External Validation , 2013, Clinical Cancer Research.

[40]  V. Acharya,et al.  Integrated network analysis and logistic regression modeling identify stage-specific genes in Oral Squamous Cell Carcinoma , 2015, BMC Medical Genomics.

[41]  Lue Ping Zhao,et al.  Gene Expression Profiling Identifies Genes Predictive of Oral Squamous Cell Carcinoma , 2008, Cancer Epidemiology Biomarkers & Prevention.

[42]  C. Farah,et al.  Gene Expression Profiling for the Purposes of Biomarker Discovery in Oral Potentially Malignant Lesions: A Systematic Review , 2013, Clinical Medicine Insights. Oncology.

[43]  David Sidransky,et al.  Emerging molecular markers of cancer , 2002, Nature Reviews Cancer.

[44]  Constantin F. Aliferis,et al.  Analysis and Computational Dissection of Molecular Signature Multiplicity , 2010, PLoS Comput. Biol..

[45]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[46]  Li Mao,et al.  Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. , 2006, Neoplasia.

[47]  Kevin C. Dorff,et al.  The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models , 2010, Nature Biotechnology.

[48]  Zhiwei Cao,et al.  Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma , 2016, PloS one.

[49]  Yung-Jen Chuang,et al.  A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell Carcinoma , 2011, PloS one.

[50]  D. Rickman,et al.  Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays , 2008, Oncogene.

[51]  T. Yen,et al.  Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature , 2015, Oncotarget.

[52]  Masaru Ushijima,et al.  Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma , 2007, Cancer science.

[53]  Toshima Z. Parris,et al.  Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma , 2014, BMC Cancer.

[54]  James Bailey,et al.  MIRAGAA - a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer , 2010, Bioinform..

[55]  T. Tokuyasu,et al.  Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis , 2011, Clinical Cancer Research.

[56]  Ruud H. Brakenhoff,et al.  Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables , 2017, Oncotarget.

[57]  F. Holstege,et al.  Dissection of a metastatic gene expression signature into distinct components , 2006, Genome Biology.

[58]  Kiran Dahiya,et al.  Updated overview of current biomarkers in head and neck carcinoma. , 2016, World journal of methodology.

[59]  Igor Jurisica,et al.  A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence , 2011, BMC Cancer.

[60]  T. Colgan,et al.  Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer , 2015, Oncogenesis.

[61]  R. Kannagi,et al.  Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma. , 2010, Auris, nasus, larynx.

[62]  A. Ziober,et al.  Lab‐on‐a‐chip for oral cancer screening and diagnosis , 2008, Head & neck.

[63]  R. Schmelzeisen,et al.  Application of fuzzy inference to European patients to predict cervical lymph node metastasis in carcinoma of the tongue. , 2005, International journal of oral and maxillofacial surgery.

[64]  R. Simon,et al.  Biomarker-adaptive threshold design: a procedure for evaluating treatment with possible biomarker-defined subset effect. , 2007, Journal of the National Cancer Institute.

[65]  N. Park,et al.  Genomic Targets in Saliva , 2007, Annals of the New York Academy of Sciences.

[66]  R. Bavle,et al.  Molecular Classification of Oral Squamous Cell Carcinoma. , 2016, Journal of clinical and diagnostic research : JCDR.

[67]  A. Kolokythas,et al.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances. , 2010, Current cancer therapy reviews.

[68]  Yorgos Goletsis,et al.  Gene expression profiling towards the prediction of oral cancer reoccurrence , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[69]  T. McShane,et al.  Development and Use of Biomarkers in Oncology Drug Development , 2004, Toxicologic pathology.

[70]  Patrick Kemmeren,et al.  Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. , 2006, Cancer research.

[71]  N. D’Silva,et al.  Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma , 2013, Journal of dental research.